NDC 23155-216

CIDOFOVIR DIHYDRATE

Cidofovir Dihydrate

CIDOFOVIR DIHYDRATE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Heritage Pharmaceuticals Inc.. The primary component is Cidofovir.

Product ID23155-216_17a6bf2d-eff0-468a-a27d-af1df2ee698c
NDC23155-216
Product TypeHuman Prescription Drug
Proprietary NameCIDOFOVIR DIHYDRATE
Generic NameCidofovir Dihydrate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-08-06
Marketing CategoryANDA / ANDA
Application NumberANDA202501
Labeler NameHeritage Pharmaceuticals Inc.
Substance NameCIDOFOVIR
Active Ingredient Strength375 mg/5mL
Pharm ClassesCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 23155-216-31

5 mL in 1 VIAL, GLASS (23155-216-31)
Marketing Start Date2012-08-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 23155-216-31 [23155021631]

CIDOFOVIR DIHYDRATE INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA202501
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2012-08-06

Drug Details

Active Ingredients

IngredientStrength
CIDOFOVIR375 mg/5mL

OpenFDA Data

SPL SET ID:44966a7e-d777-40fb-956f-d0f31f737848
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199388
  • UPC Code
  • 0323155216318
  • Pharmacological Class

    • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • DNA Polymerase Inhibitors [MoA]
    • Nucleoside Analog [EXT]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.